Sep 30, 2020 / 03:00AM GMT
Ziyi Chen - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Good morning and evening to our global investors. Thank you for joining CStone call today regarding the newly announced collaboration with Pfizer. This is a Ziyi Chen, China health care analyst at Goldman Sachs.
Before we kick off the session, I would like to highlight that this call is strictly for clients of Goldman Sachs only, and this conversation is not intended for the media and is off for the record. Participants will be removed from the call if they cannot be properly identified. And this call is not for the purpose of sharing or receiving non-public information.
So today, we are honored to have CStone's management team online to share their thoughts on the collaboration with Pfizer, the new transaction, and also answer investors' questions.
Joining the call includes Dr. Frank Jiang, Chairman and CEO; Ms. Shirley Zhao, Greater China General Manager, Head of Commercial Operations; Dr. Jianxin Yang, Chief Medical Officer; Dr. Bin Yuan, Chief Strategy and Business Officer; and Mr. (inaudible), Chief
CStone Pharmaceuticals and Pfizer Inc Enter into Strategic Collaboration to Address Oncological Needs in China Call Transcript
Sep 30, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers